对于寿命有限的低风险基底细胞癌（BCC）患者，可以考虑进行积极监测；然而，寿命估计并不容易获得。退伍军人健康管理局（VHA）的护理评估需求（CAN）分数可能可以解决这个问题。我们研究了CAN分数在预测癌症患者的1年、3年和5年死亡率方面的表现。这项回顾性队列研究使用了VHA全国性电子医疗记录数据。基于适应度、判别度和校准度的测试，评估了CAN分数在预测BCC患者死亡率方面的表现。在2013年至2018年间，共有54,744名接受BCC治疗的退伍军人的数据显示，CAN分数在多个测试中表现出良好的死亡率预测能力。对于3年死亡率，CAN分数阈值为90时的阳性预测值为55%，在识别中期存活患者方面具有临床实用性。本研究依赖于诊断代码和程序代码的组合来识别BCC病例。CAN分数有潜力通过为临床医生提供寿命预期估计和促进积极监测患者交流的方式来提高退伍军人的癌症护理质量。版权所有 © 2023 Elsevier Inc. 发布

Active surveillance may be considered for low-risk basal cell carcinomas (BCC) in patients with limited life expectancy; however, estimates of life expectancy are not readily available. Veterans Health Administration's (VHA) Care Assessment Need (CAN) score may address this problem.We examined the CAN score's performance in predicting 1-, 3-, and 5-year mortality in United States (US) veterans with BCC.This retrospective cohort study used national VHA electronic medical record data. The CAN score's performance in the prediction of mortality in veterans with BCC was evaluated based on tests of goodness-of-fit, discrimination, and calibration.For 54,744 veterans with BCC treatment encounters between 2013 and 2018, the CAN score performed well in the prediction of mortality based on multiple tests. A threshold CAN score of 90 had a positive predictive value of 55% for 3-year mortality, clinically useful in identifying patients with intermediate-term survival.The study relied upon the combination of diagnosis codes and procedures codes to identify BCC cases.The CAN score has the potential to improve the quality of cancer care for veterans by providing clinicians with an estimate of life expectancy and facilitating conversations in cases where active surveillance can be considered.Copyright © 2023. Published by Elsevier Inc.